RO81943B - Procedeu de preparare a unor derivati de piridoxina - Google Patents

Procedeu de preparare a unor derivati de piridoxina

Info

Publication number
RO81943B
RO81943B RO104319A RO10431981A RO81943B RO 81943 B RO81943 B RO 81943B RO 104319 A RO104319 A RO 104319A RO 10431981 A RO10431981 A RO 10431981A RO 81943 B RO81943 B RO 81943B
Authority
RO
Romania
Prior art keywords
preparation
methyl
pyridoxine
general formula
see formula
Prior art date
Application number
RO104319A
Other languages
English (en)
Other versions
RO81943A (ro
Inventor
Marcel Descamps
Marcel Urbain
Original Assignee
S.A. Labaz N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S.A. Labaz N.V. filed Critical S.A. Labaz N.V.
Publication of RO81943B publication Critical patent/RO81943B/ro
Publication of RO81943A publication Critical patent/RO81943A/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Inventia prezinta un procedeu de preparare a unor derivati de piridoxina cu formula generala I: (vezi formula) în care R reprezinta un radical (vezi formula) în care n este 1, X si X1 sunt diferiti si reprezinta hidrogen sau metil si R1 reprezinta o grupa fenil sau fenil mono sau disubstituit cu fluor, clor, brom, metil, etil, n-propil, izopropil si metoxi, constînd din aceea ca 3-0-(2,3-epoxipropil)-alfa, alfa-izopropilidenpiridoxolul cu formula II: (vezi formula) se trateaza la reflux si în metanol ca solvent, cu o amina cu formula generala III: (vezi formula) în care R are semnificatiile de mai sus, pentru a obtine un cetal care apoi este hidrolizat în mediu puternic acid, la o temperatura cuprinsa între 25 si 80 degree C pentru a obtine derivatul de piridoxina I sub forma de baza libera, care, eventual, poate fi transformat prin tratare cu un acid organic sau anorganic adecvat în sarea de aditie netoxica.
RO81104319A 1980-05-19 1981-05-18 Procedeu de preparare a unor derivati de piridoxina RO81943A (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19

Publications (2)

Publication Number Publication Date
RO81943B true RO81943B (ro) 1983-05-30
RO81943A RO81943A (ro) 1983-06-01

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
RO81104319A RO81943A (ro) 1980-05-19 1981-05-18 Procedeu de preparare a unor derivati de piridoxina

Country Status (32)

Country Link
US (1) US4374841A (ro)
EP (1) EP0040591B1 (ro)
JP (1) JPS5711966A (ro)
AR (1) AR226356A1 (ro)
AT (1) ATE3859T1 (ro)
AU (1) AU542463B2 (ro)
BG (1) BG35327A3 (ro)
CA (1) CA1152080A (ro)
CS (1) CS223842B2 (ro)
DD (1) DD159071A5 (ro)
DE (1) DE3160480D1 (ro)
DK (1) DK217481A (ro)
EG (1) EG15890A (ro)
ES (1) ES502276A0 (ro)
FI (1) FI811525L (ro)
GR (1) GR82343B (ro)
HU (1) HU183441B (ro)
IE (1) IE51179B1 (ro)
IL (1) IL62602A (ro)
IN (1) IN151915B (ro)
IS (1) IS1183B6 (ro)
MA (1) MA19147A1 (ro)
NO (1) NO811680L (ro)
NZ (1) NZ196766A (ro)
OA (1) OA06811A (ro)
PL (1) PL129213B1 (ro)
PT (1) PT72992B (ro)
RO (1) RO81943A (ro)
SU (1) SU1077566A3 (ro)
YU (1) YU126281A (ro)
ZA (1) ZA812448B (ro)
ZW (1) ZW9681A1 (ro)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
EP1169322B8 (en) 1999-03-08 2006-09-13 Medicure Inc. Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
EP1196171A2 (en) 1999-07-13 2002-04-17 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
EP1210117A2 (en) * 1999-08-24 2002-06-05 Medicure International Inc. Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
DE60133323T2 (de) 2000-02-29 2009-03-05 Medicure International Inc. Cardioprotektive Phosphonate
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
ATE364595T1 (de) 2000-07-07 2007-07-15 Medicure Int Inc Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
WO2004084910A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
CN101014357A (zh) * 2004-07-07 2007-08-08 麦迪库瑞国际公司 利用血小板聚集药物的组合疗法
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
EP1817288A4 (en) * 2004-10-28 2009-08-26 Medicure Int Inc DUAL ANTIPLÄTTCHEN / ANTIKOAGULANS PYRIDOXINANALOGE
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
JP2009517411A (ja) * 2005-11-28 2009-04-30 メディキュア インターナショナル インコーポレーテッド 心血管及び関連病状の処置のための調剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207133A1 (es) * 1973-02-20 1976-09-15 Ciba Geigy Ag Procedimiento para la elaboracion de derivados de 1-piridiloxi 1-pirimidiniloxi y 1-piraziniloxi-2-hidroxi-3-amino-propano
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
IE811085L (en) 1981-11-19
AR226356A1 (es) 1982-06-30
ZW9681A1 (en) 1982-01-20
RO81943A (ro) 1983-06-01
IS2631A7 (is) 1981-11-11
NO811680L (no) 1981-11-20
US4374841A (en) 1983-02-22
IL62602A (en) 1984-06-29
NZ196766A (en) 1984-02-03
ATE3859T1 (de) 1983-07-15
SU1077566A3 (ru) 1984-02-29
DK217481A (da) 1981-11-20
IL62602A0 (en) 1981-06-29
BG35327A3 (en) 1984-03-15
JPS5711966A (en) 1982-01-21
IE51179B1 (en) 1986-10-29
CA1152080A (en) 1983-08-16
FI811525L (fi) 1981-11-20
EP0040591B1 (fr) 1983-06-22
AU542463B2 (en) 1985-02-21
ES8203845A1 (es) 1982-04-01
IS1183B6 (is) 1985-05-13
HU183441B (en) 1984-05-28
PT72992B (en) 1982-07-01
GR82343B (ro) 1984-12-13
PT72992A (en) 1981-06-01
EP0040591A1 (fr) 1981-11-25
PL129213B1 (en) 1984-04-30
MA19147A1 (fr) 1981-12-31
YU126281A (en) 1984-02-29
PL231193A1 (ro) 1982-07-05
DE3160480D1 (en) 1983-07-28
IN151915B (ro) 1983-09-03
ES502276A0 (es) 1982-04-01
ZA812448B (en) 1982-04-28
DD159071A5 (de) 1983-02-16
CS223842B2 (en) 1983-11-25
EG15890A (en) 1987-03-30
AU7053581A (en) 1981-11-26
OA06811A (fr) 1982-12-31

Similar Documents

Publication Publication Date Title
RO81943B (ro) Procedeu de preparare a unor derivati de piridoxina
DK0944617T3 (da) Krystaller af benzimidazolderivater og deres fremstilling
KR850001210A (ko) 피롤로-[1,2-a] 이미다졸 및 이미다조[1,2-a]피리딘유도체의 제조방법
ES2000910A6 (es) Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos
ES450381A1 (es) Procedimiento para preparar derivados de acido indanacetico.
GB855719A (en) Process for the production of 4-nitro-diarylamines
FI892327A (fi) Foerfarande foer framstaellning av cykliska sulfat.
GB977071A (en) Hydroxylamine derivatives and process for making them
ES438757A1 (es) Un procedimiento de obtencion de las meta-trifluormetilben- cilaminas sustituidas al nitrogeno.
ATE30718T1 (de) Herstellung von 1-benzyl azetidin-3-ol und von dem entsprechenden halid acid.
KR840000556A (ko) 5,6,7,7a-테트라하이드로-4H-티에노(3,2-c)-피리딘-2-온 유도체의 제조방법
ES8602786A1 (es) Derivados de pirimidoisoquinolina
ES378202A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles sustituidos en el grupo amino.
JPS51133243A (en) Process for preparing phthalamic acid ester derivatives
DK566181A (da) Fremgangsmaade til fremstilling af n-pyrrolylpyridazinaminderivater
ES434406A1 (es) Procedimiento para preparar derivados de naftiridina.
ES444644A1 (es) Un procedimiento de preparacion de derivados de la tienopi- ridina.
ES450586A1 (es) Procedimiento para preparar 1-azidoalquilimidazoles.
GB1035919A (en) Process for the manufacture of 4-amino-3-nitroazobenzene and derivatives thereof
KR830004273A (ko) 살균 작용을 가진 이조옥사졸릴카르복스 아닐리드류의 제조법
GB1512168A (en) Process for preparing 1-(beta-cyanoethylamino)-3-acylaminobenzenes
GR27795B (el) Μεθοδος δια την παρασκευην νεων ετεροκυκλικων ενωσεων.
FI863897A (fi) Kemiskt foerfarande.
NL7605541A (nl) Werkwijze ter bereiding van nieuwe organische verbindingen.
ES291049A1 (es) Procedimiento para la preparación de nuevos derivados de 3-azabiciclo-(3,2,2)-nonano